Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.40 |
| ▸ | CCNE1 | P24864 | 14/20 | 0.37 |
| ▸ | CDK2 | P24941 | 14/20 | 0.37 |
| ▸ | GSK3B | P49841 | 10/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3697656 | 0.86 | TSHR (0.39) | EPHX1CCNE1CDK2CYP3A4TSHR | |
| SCHEMBL30519023 | 0.83 | EPHX1 (0.56) | EPHX1CCNE1CDK2GSK3BBCHE | |
| SCHEMBL23188170 | 0.80 | EPHX1 (0.46) | EPHX1CCNE1CDK2GSK3BBCHE | |
| SCHEMBL3697937 | 0.79 | EPHX1 (0.65) | EPHX1BCHEGAATSHR | |
| SCHEMBL30701787 | 0.79 | CYP3A4 (0.37) | EPHX1CCNE1CDK2CYP3A4TSHR | |
| SCHEMBL3692108 | 0.78 | EPHX1 (0.44) | EPHX1TSHRCYP2C19 | |
| SCHEMBL27714015 | 0.77 | SLC6A1 (0.40) | EPHX1TSHR | |
| SCHEMBL3694867 | 0.77 | EPHX1 (0.49) | EPHX1BCHEGAATSHR | |
| Hydrochloric Acid SCHEMBL27694096 | 0.75 | SLC6A1 (0.39) | EPHX1TSHR | |
| SCHEMBL3694817 | 0.74 | GAA (0.53) | EPHX1BCHEGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100331546-A1 | METHOD FOR OPTICAL RESOLUTION OF ALKYL PIPERIDIN-3-YL CARBAMATE AND INTERMEDIATE THEREFOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-12-30 | — | — | US | disclosed |
| EP-2248803-A1 | METHOD FOR OPTICAL RESOLUTION OF ALKYLPIPERIDIN-3-YL CARBAMATE AND INTERMEDIATE THEREFOR | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331546-A1 | METHOD FOR OPTICAL RESOLUTION OF ALKYL PIPERIDIN-3-YL CARBAMATE AND INTERMEDIATE THEREFOR | FAR1, NOTUM, CYP51A1 | EPHX1 4038/4885CCNE1 3781/4885CDK2 3421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.